Eveliqure Biotechnologies

About Eveliqure Biotechnologies
Eveliqure is a game-changer vaccine company, championing novel technologies to make the world safe from diarrhoeal diseases caused by Shigella and ETEC pathogens. Eveliqure developed a combined vaccine, deemed to be the ideal scenario by the World Health Organization. Addressing this health problem, endemic in resource-poor countries, is vital, as it is a leading cause of child mortality in the world, impacts travelers to these areas, and costs billions of dollars to address.

CEO, Gabor Somogyi (MBA '03)